← All Lipocine INC filings

Lipocine INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
LPCN
Lipocine INC
SCHEDULE: Squadron Master Fund Acquires 9.8% Stake in Lipocine Inc.
Squadron Master Fund LP, along with its affiliates, has reported beneficial ownership of 810,000 shares, representing 9.8% of Lipocine Inc.'s common stock.
NASDAQ
LPCN
Lipocine INC
SCHEDULE: Lipocine Inc. Ownership Update by Squadron Funds
Squadron Master Fund LP and its affiliates report a 6.2% stake in Lipocine Inc. common stock as of March 31, 2026.
NASDAQ
LPCN
Lipocine INC
SCHEDULE: Squadron Master Fund Discloses 9.5% Stake in Lipocine Inc.
Squadron Master Fund LP and its affiliates reported a 9.5% beneficial ownership stake in Lipocine Inc. common stock, held for ordinary business purposes.
NASDAQ
LPCN
Lipocine INC
SCHEDULE: Squadron Entities Disclose Significant Lipocine Inc. Stake
Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn, and William Blank have reported beneficial ownership of Lipocine Inc. common stock, with Squadron Capital Management and its partners holding 9.0%.